---
title: "Lung Cancer Screening - DAP C"
ocid: "ocds-h6vhtk-06d7c8"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06d7c8"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06d7c8.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06d7c8.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ESSEX INTEGRATED CARE BOARD"
published: "2026-07-30"
---

# Lung Cancer Screening - DAP C

Buyer: NHS ESSEX INTEGRATED CARE BOARD  
Current stage: Award  
OCID: ocds-h6vhtk-06d7c8

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06d7c8)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06d7c8.json)

## Summary

The NHS Essex Integrated Care Board has initiated a Provider Selection Regime (PSR) to award a contract for lung cancer screening services across North East Essex and Suffolk. The process commenced on 30th July 2026, with representations to be submitted by 12th August 2026. The contract is currently in the Intention to Award stage, and it is managed under the Health Care Services Regulations 2023, excluding the Public Contract Regulations 2015. GP Primary Choice Ltd, an existing provider, is the sole bidder and is responsible for delivering the service, which involves conducting lung health checks and referring patients for CT scans. The contract is valued at £1,096,896 annually and spans from 1st September 2026 to 31st March 2028, funded by the cancer alliance outside the ICB budget.

This procurement presents a significant opportunity for businesses in the healthcare sector, especially those adept in medical practice services, quality audits, and service integration. Companies with strengths in innovation, service sustainability, and addressing health inequalities would be well-suited to this contract. GP Primary Choice Ltd’s role as a supplier underscores the need for strong community ties and a comprehensive understanding of local demographics and patient needs. As the contract facilitates ongoing growth in lung cancer screening, it supports business expansion through the delivery of integrated cancer care services in partnership with primary care and acute services. The focus on value for money and social benefits aligns with national ambitions to improve early-stage cancer diagnoses.

## Notice

The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget.

### Lot Information

Lot 1

The lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan. The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme. The contract is a cost and volume contract with GPPC paid PS41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at PS22,260 for 1 PA per week. This means the annual contract value is PS1,096,896. This is funded by the cancer alliance and not from the ICB budget. The new contract will commence 1st September 2026 and conclude on 31st March 2028. The provider is an existing provider, who is currently satisfying the requirements of the existing contract. The provider has been assessed against the criteria specified for this DAP C process: Quality & Innovation 30%. Value 20%. Integration, Collaboration & Service Sustainability 25%, Access Health Inequalities and Choice 20%; Social Value 5%. Key criteria were specified, and assessment against each criterion was assessed based on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. The considerable change test has been completed and the unit price has not changed and the activity growth is within typical patient growth.

### Procurement Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: Kevin.Edwards@Attain.co.uk The Decision Maker for this award was the ICB Executive Board. There were no conflicts of interest declared by individuals making the decision. All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2. The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/072248-2026 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 30 Jul 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 27 Apr 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,096,896 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ESSEX INTEGRATED CARE BOARD |
| Locality | CHELMSFORD |
| Post town | Chelmsford |
| Postcode | CM1 1QH |
| Country | England |
| ITL 1 | TLH East (England) |
| ITL 2 | TLH3 Essex |
| ITL 3 | TLH36 Heart of Essex |
| Local authority | Chelmsford |
| Electoral ward | Moulsham and Central |
| Westminster constituency | Chelmsford |
| Delivery location | TLH3 Essex |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | GP PRIMARY CHOICE |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85100000 - Health services
- 85121000 - Medical practice services

## Release History

- 30 Jul 2026 at 13:36 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/072248-2026

## Notice URLs

- http://www.england.nhs.uk
- https://www.essex.icb.nhs

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06d7c8. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06d7c8.json.